Oura Pulls $2.2 Billion IPO at Last Minute — Street Doubts the Story
Oura scrapped a $2.2 billion IPO that was roughly five times oversubscribed, blaming market uncertainty. Wall Street suspects the real story is the $15.6 billion valuation and an insider cash-out.
By Daniel Okafor
4 min read
Updated
What's News
- Oura pulled its IPO on Sept. 29, hours before pricing, after a roadshow that drew about five times oversubscribed demand
- At the top of the proposed $40 to $44 range, Oura's fully diluted valuation would have reached $15.6 billion on 50 million shares
- Only 13.5 million of the 50 million shares (27%) were to be newly issued by Oura; 36.5 million (73%) were to be sold by existing shareholders
- At the $42 midpoint, the split would have delivered about $567 million to Oura and roughly $1.53 billion to selling shareholders
- The S&P 500 is up more than 13% in 2026 and sits less than 1% off record highs, undercutting the 'market conditions' explanation
Oura, the smart-ring maker that had been roughly five times oversubscribed for a public offering worth as much as $2.2 billion, called off its IPO hours before pricing on Sept. 29.
The Finland-based company had proposed selling 50 million shares at $40 to $44 apiece. At the $42 midpoint, the deal would have raised about $2.1 billion in gross proceeds. At the top of the range, Oura's fully diluted valuation would have hit $15.6 billion.
Oura blamed "uncertainty in the IPO market" for the postponement. CEO Tom Hale told investors the company has the "luxury of choosing our moment." Oura also said the business is "profitable, growing meaningfully, and the business has further strengthened since beginning the IPO process."
But Wall Street is not buying the explanation. The S&P 500 is up more than 13% in 2026, and the index sits less than 1% off record highs. Gil Luria, head of technology research at D.A. Davidson, called the market backdrop "remarkably stable."
Did market conditions actually force the delay?
Other recent IPO pullbacks came with explicit explanations. Holtec Nuclear, Bamboo Insurance, and Amaero all shelved offerings in September, each citing specific pressures.
Holtec pointed to "rising energy costs, elevated global trade tensions, ongoing military conflicts, and mounting inflation fears." Oura offered no such specifics.
"They always blame it on market conditions," said Jay Ritter, director of the IPO Initiative at the University of Florida's Warrington College of Business. "They never say, 'Uh, the reason we're pulling the IPO is we had unrealistic expectations about how much we're worth.'"
Luria was more pointed. "To say that market conditions were the reason for the IPO postponement seems like a little bit of a stretch," he said, citing a healthy consumer and a resilient economy.
Kat Siu, vice president at financial services firm IPOX, was blunter still. "What else are you gonna say? 'We aren't meeting our expectations.' I mean, that's just not a thing to say to the public."
Is the valuation too rich?
Some prospective buyers passed on the deal because of concerns over Oura's target valuation, Bloomberg reported last week, citing people familiar with the matter.
At a $15.6 billion fully diluted valuation, Oura's multiple looks very different depending on how investors frame the business. As an AI-enabled digital-health platform, the number can "kind of be justified," Siu said. As a pure ring manufacturer, "that valuation is pretty hefty."
Luria drew a line back to hardware-heavy debuts that have soured. Peloton priced at $29 per share in 2019 and has since dropped more than 82%. GoPro went public at $24 in 2014 and has plunged over 94%.
"Investors have a long memory," Luria said. "It really was a similar type of story about the secular trend for health and the importance of tracking and promoting it. Those ideas in the end did not work out."
Was the deal structure the real problem?
The structure may have given investors additional reason to step back. Only 13.5 million of the 50 million shares, or 27%, were to be newly issued by Oura. The remaining 36.5 million shares, or 73%, were to be sold by existing shareholders.
At the $42 midpoint, that split would have delivered roughly $567 million in gross proceeds to Oura and approximately $1.53 billion to selling shareholders.
"That's a flag for the market," Siu said. "It's signaling that this IPO is not meant for growth."
How big is the Apple risk?
Oura may dominate the smart-ring segment, but the broader wearables market belongs to giants. Apple, Alphabet's Google, Garmin, Fitbit and Whoop all chase the same health-tracking dollars.
Apple already offers sleep monitoring and heart-rate tracking through the Apple Watch. A dedicated ring is the obvious next product.
"All Apple has to decide to do is come up with a ring, and Oura's business, for most intents and purposes, doesn't need to exist," Luria said.
Ritter questioned the addressable market more broadly. "It's a great product from a company that has been growing rapidly and is profitable," he said. "But just how big a market is this?"
What's next
Oura declined to comment on a revised timeline. The company had already raised $875 million in a Series E round at an $11 billion valuation.
Hale's framing — that Oura can wait — is plausible for a profitable, growing business with private capital already in the bank. The harder question is what Oura can offer public-market investors the second time around that it could not in late September, given the same competitive backdrop, the same insider-heavy structure, and the same skepticism about a single-product hardware story priced for software multiples.
Original: businesswire.com
More from Daniel Okafor
Show full bio
Correspondent covering business strategy at Business Bearings.
586 articles